Abbott Laboratories
(NYSE:ABT)
$
112.3286
0.0186 (0.02%)
Market Cap: 194.83 Bil
Enterprise Value: 202.46 Bil
PE Ratio: 34.14
PB Ratio: 4.90
GF Score: 93/100 Abbott Laboratories at JPMorgan Healthcare Conference Transcript
Jan 10, 2023 / 05:00PM GMT
Release Date Price:
$113.85
(+1.52%)
Robert Justin Marcus
JPMorgan Chase & Co, Research Division - Analyst
Good morning, everyone. Welcome. I'm Robbie Marcus, med tech analyst at JPMorgan. Really happy to introduce our next session with Abbott Labs and the CEO, Robert Ford. Robert, thanks for joining.
Robert B. Ford
Abbott Laboratories - Chairman of the Board, President & CEO
Thanks for having us.
Questions & Answers
Robert Justin Marcus
JPMorgan Chase & Co, Research Division - Analyst
So I want to start out, 2022 was an interesting year for everyone. Turning the calendar page, we're now in 2023. I thought it would be good to start off with how you see the world, the outlook for Abbott this year.
Robert B. Ford
Abbott Laboratories - Chairman of the Board, President & CEO
Sure. I mean I think you change from one month to the other, one day to the other, it doesn't all go away. I'd say -- I'm not going to give any kind of specific guidance for Abbott today. We'll do that in a
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot